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For the laboratory confirmation of cellular hypersensitivity responses the inhibition of cell
migration is widely used. This procedure is based upon the observations of Rich and Lewis
(1932), who found a reduced radial migration of macrophages from spleen explants of
tuberculin-sensitive guinea-pigs in the presence of tuberculin, in contrast to those originat-
ing from Mantoux-negative animals. The inhibition of macrophage migration is nowadays
most frequently examined in the manner described by George and Vaughan (I962): from
a capillary tube containing the peritoneal exudate of guinea-pigs its cells migrate out
in the same way as do the motile cells of the spleen explant, and this cell migration also
may be inhibited by specific antigens. According to the investigations of David, Al-Askari,
Lawrence, and Thomas (I964) the cell migration is inhibited by antigens causing delayed
hypersensitivity only, and this phenomenon is unrelated to humoral immunity. The inhibi-
tion is due to a soluble protein (migration inhibitory factor, MIF) synthesized by the
immunocompetent lymphocytes found between the peritoneal cells when the former
come in contact with the specific antigen, MIF decreasing the motility of macrophages
(David, I966; Bloom and Bennett, I966).
The studies ofS0borg and Bendixen (1967) and S0borg (i 967) demonstrated the migra-
tion of the leucocytes separated from the peripheral blood leaving the capillary tube con-
tainer in the same way as the peritoneal macrophages; the migration of leucocytes can also
be inhibited by antigens causing delayed hypersensitivity. The inhibition of leucocyte
migration has since become widely used to investigate antimicrobial, antitumour, and
antitransplant immunity of the delayed type, and also autoimmune diseases and drug
allergy (Revillard, 1971; Dobozy, Hunyadi, and Simon, 1973).
The present paper gives an account of our investigations in performing leucocyte
migration tests with uveal pigment as antigen from the blood of patients suffering from
sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome, respectively. In
both diseases, earlier anti-uveal antibodies and lymphocytes hypersensitive to uveal antigen
were demonstrated in the peripheral blood (Kahan, Sztanojevits, Szabados, Vass, and
Szabo, I964; Mills and Shedden. I965; Hammer, 197I; Wong, Anderson, and O'Brien,
I97I)e
Marak, Font, Johnson, and Alepa (I 97 I) and Marak, Aye, and Alepa (I 973) prepared
separately uveal and pigment epithelial antigens and found blastogenic activity of the latter
only in sympathetic ophthalmitis.
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Methods
The examinations were carried out on two patients suffering from the Vogt-Koyanagi-Harada syn-
drome, four with sympathetic ophthalmitis, and eight ophthalmologically healthy subjects. With the
exception of the last patient with sympathetic ophthalmitis, they were the same as those on whom
lymphocyte transformation tests had previously been carried out with uveal pigment (Hammer, I 971).
Uveal pigment, prepared from the bovine eye and not containing soluble proteins, was used as
antigen (Woods, I925).
The leucocyte migration test was performed in the manner described by Dobozy, Schneider,
Hunyadi, and Simon (1973). Plasma containing the erythrocytes or leucocytes was separated by
sedimentation from blood samples collected with sodium citrate to inhibit coagulation. The leuco-
cyte-rich plasma was centrifuged and the cells were washed with Parker I99 medium. The washed
leucocyte suspension was drawn into a capillary tube I00 mm. in length and I-2 mm. in diameter,
and one end of the tube was then flame-sealed. It was next centrifuged for I0 min. at 8oo G, and
the tube was then cut at the boundary of the cell and liquid layers. The part containing the cells
was fixed onto the bottom of a tissue-culture vessel with solid paraffin, and covered with Parker I 99
medium containing I00 ,ug.//ml. streptomycin and penicillin. At least four cultures were prepared from
each patient examined: the uveal pigment was added to two of these, and the other two served as
controls. After cultivation for 24 hrs at 37 0C., the migrated area was projected, circumscribed, and
measured planimetrically. The extent of inhibition is expressed by the migration index, which is the
ratio of migrations of the culture containing the antigen and the control culture, respectively.
Results
The first step in the experiments was the determination of the optimal concentration of the
uveal pigment which gave rise to the most extensive inhibition of migration (Table I).
Table I Determination ofoptimal migration-inhibitory concentra-
tion of uveal pigment
Concentration of Migration index
uveal pigment
(pg/ml.) V-K-H syndrome Sympathetic ophthalmitis
2 0-83 0o76
5 5o-6 O°54
20 o*-8 o-6i
100 0°70 o.58
Ten cultures each were prepared from one patient with sympathetic ophthalmitis and
one with the Vogt-Koyanagi-Harada syndrome; 2 ,ug./ml. uveal pigment was added to
each of two cultures, 5,ug./ml. to each of a second pair, 20 ,ug./ml. to each of a third pair,
and I00 pg./ml. to each of a fourth pair. The two remaining pairs of cultures served as
controls. In both patients the greatest inhibition of migration was obtained with 5 ug./ml.
uveal pigment, and further increase of the amount of antigen no longer decreased the leuco-
cyte migration. For this reason, all further experiments were carried out with 5 ,ug./ml.
uveal pigment.
The experimental results are summarized in Table II. In all patients with sympathetic
ophthalmitis or the Vogt-Koyanagi-Harada syndrome, the 5 PLg./ml. uveal pigment
reduced the leucocyte migration, and in every case the migration index was less than o-8.
The leucocyte migration was not decreased in the ophthalmologically healthy subject;
the migration index was between o-87 and i o8 in all of them.
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Table II Effect of5 ,ug./ml. uvealpigment on leucocyte migration
in patients with Vogt-Koyanagi-Harada syndrome and sympathetic
ophthalmitis, and in healthy subjects
Patient No. Diagnosis Migration index
I V-K-H syndrome o0-6
2 ,,043
3 Sympathetic ophthalmitis 0-54
4 ,, o-8o
5 o-62
6 ,, 074
7 Healthy I 04
8 ,, 0-92
9 ,, o-87
10 ,I *02
II ,, I08
I2 ,, o96
13 O9I
'4 ,, o095
Discussion
Sympathetic ophthalmitis is a granulomatous uveitis developing in both eyes after a
penetrating injury to one eye; it is in all probability an autoimmune process induced by
immunocompetent lymphocytes coming into contact with the uveal pigment of the injured
eye. The antigenic role of the uveal pigment in the pathogenesis of the disease was first
suspected by Elschnig (I91o), and it was later prepared free from soluble proteins by
Woods (I 92 I) from bovine uvea.
Friedenwald (1934) injected this pigment intracutaneously into patients with sympa-
thetic ophthalmitis; 2 to 3 week laters the injected area was excised, and epithelioid cells
surrounded by a lymphocytic reaction pathognomonic of sympathetic ophthalmitis were
found. Collins (I949) injected uveal pigment suspended in Freund's adjuvant into the
paw of guinea-pigs and induced thereby a very intense lymphocytic, granulocyte-free
infiltration of the uvea, which corresponded in every respect to the pathology of sympa-
thetic ophthalmitis. In recent years a number of authors have been able to demonstrate
antibodies to the uveal pigment in the serum of patients with sympathetic ophthalmitis
(Kahan and others, I964; Mills and Shedden, I965), and lymphocytes sensitized against
uveal pigment in the peripheral blood (Hammer, 1971; Wong and others, 1971; Marak
and others, 1973). Apart from the eye, the Vogt-Koyanagi-Harada syndrome is accom-
panied by a lymphocytic granulocyte-free infiltration of the various tissues containing
melanin with consequent widespread damage, and it is possible to detect antibodies
circulating in the serum of these patients, and, by means of the lymphocyte transformation
test, lymphocytes sensitized against melanin in the peripheral blood (Kahan and others,
I964; Hammer, 197I). Circulating anti-melanin antibodies have also been successfully
demonstrated in vitiligo, one of the signs found in the Vogt-Koyanagi-Harada syndrome
(Langhof, Feuerstein, and Schabinski, I965).
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A number of methods are employed in vitro in various autoimmune diseases to confirm
the existence of delayed-type hypersensitivity. At times, however, the various tests give
different results in the same patient; for example, the investigations of Nerup, Anderson,
and Bendixen (I 969) showed an inhibited migration of leucocytes originating from patients
with idiopathic Addison's disease, by a foetal adrenal extract, while this antigen did not
induce the blastic transformation of lymphocytes in the same patients.
In certain autoimmune diseases the study of pathogenesis is made difficult by the occur-
rence of an inhibitory factor interfering with lymphocyte reactivity (Gery-Brand-Auraban,
Benezra, Jacob, and Davies, I968). Consequently it is advisable to use various methods to
confirm the autoimmune nature of different diseases in vitro.
In both sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome, anti-
melanin autoantibodies and melanin-sensitized lymphocytes have been demonstrated in
the peripheral blood. The finding that leucocyte migration is specifically inhibited by uveal
pigment in these diseases further supports the idea of their cellular autoimmune nature.
Summary
A study was made with the leucocyte migration test of the cellular hypersensitivity to
uveal pigment of patients suffering from sympathetic ophthalmitis and the Vogt-Koyanagi-
Harada syndrome. It was found that 5 ug./ml. uveal pigment decreased the leucocyte
migration of these patients while that of ophthalmologically healthy subjects remained
undisturbed.
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